Nine separate patent holders have asserted rights against a single COVID-19 vaccine, Comirnaty, since August 2022. Two more have asserted

On August 18, 2023, the FDA approved Eylea HD, Regeneron’s 8 mg reformulation of its blockbuster eye drug aflibercept. Nine

In October 2001, the United States government came within a phone call of doing something it had never done to

On March 20, 2026, a secondary patent covering Novo Nordisk’s semaglutide formulation expired in India. Within days, Torrent Pharmaceuticals and

Samsung Bioepis launched Benepali, a biosimilar of Amgen’s Enbrel (etanercept), across the European Union on January 16, 2016 [4]. Ten

On November 12, 2003, U.S. Patent 5,736,137 changed hands. The patent covers the chimeric antibody that became Rituxan, and the

The Short Answer Search a drug’s core patent on Google Patents, Espacenet, or the USPTO’s own Patent Public Search, and

On February 9, 2026, Brazil’s Chamber of Deputies voted 337 to 19 to fast-track a bill declaring tirzepatide, the active

A Supplementary Protection Certificate in Germany and a Patent Term Extension in the United States both advertise the same headline